PL Stock — Planet Labs PBC

Up next

Next earnings call

Dec 4, 2026 Est · unconfirmed · in 11 wks

Latest filing: 10-Q

filed Sep 3, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

$378.28M

Trailing 12 months

Net income (TTM)

−$359.87M

Trailing 12 months

Revenue growth YoY

+58.1%

Year over year

Operating margin

-27.2%

Trailing 12 months

P / E (TTM)

—

Trailing earnings

FCF yield

0.4%

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

$415.13M

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

+18.2%

Year over year · more shares

Price change (1Y)

+65.6%

Trailing year

Short interest

8.0%

Latest settlement · 5.9 days to cover

View all 115 metrics

Equibles Research

our published analysis of this company

Research Thesis July 16, 2026

Rocket Lab: Backlog is converting, but the $39B market cap is paying for a Neutron debut the company has yet to validate

Rocket Lab enters Q2 2026 with record backlog of $2,219.8M and guided revenue of $225.0M–$240.0M, yet the stock trades at -55.2% from its $150.23 high on a $39.0B market cap against $679.6M of trailing revenue — a gap the equity-funded growth model and the un-flown Neutron debut have to close.

Equibles Rating

blended score · not investment advice

Overall

Sell

SellHoldBuy

Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High

Market backdrop VIX 17.2 · elevated Equity put/call 0.56

Technical

price trend

Sell

50 / 200-day cross No cross

Price vs 200-day avg −41%

below

Price vs 50-day avg −27%

below

RSI (14) 22

oversold

MACD trend Negative

52-week position 15%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Very Weak

1-month return −34%

trailing

6-month return −50%

trailing

YTD return −19%

this year

Relative strength −66%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $22 › 200d $27 — 200d above 50d

Institutional flow Accumulating

+16% holders QoQ · +129 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Rising

8.03% of float · ▲ +5.3% MoM · 5.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

488 holders — near 3-yr high, broad support

Squeeze score 61

elevated · 0–100

Fundamentals

Strong

Revenue growth +26%

Y/Y

Gross margin 56%

contracting

EPS growth −90%

Y/Y

Free cash flow $57.6M

Quant / Vol

risk profile

Very High

Volatility 93%

annualized · 1-yr

Max drawdown −69%

past year

ATR 7.5%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the Earnings Call filed Sep 3, 2026

Q3

Revenue $101M – $105M

prior qtr $116.05M midpoint −11.2% QoQ

Non-GAAP gross margin Non-GAAP 56% – 58%

Capital expenditures $30M – $37M

full fiscal year 2027

Revenue Initiated $430M – $441M

prior FY $307.73M midpoint +41.5% Y/Y

Non-GAAP gross margin Non-GAAP Initiated 55% – 57%

Capital expenditures Initiated $100M – $115M

Adjusted EBITDA Non-GAAP Initiated $3M – $10M

Prior guidance period ended · from the Earnings Call filed Dec 13, 2021

Revenue · full year $129M – $131M

CAPEX spend · fourth quarter of fiscal 22 $5M – $7M

Full year CapEx · full year $13M – $16M

CapEx as a percentage of revenue · full year 10% – 12%

Guided vs delivered · last 1 settled

Revenue full year

guided $129M – $131M

guided $129M – $131M $131.21M Beat +0.9%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell

3 · 4 · 0

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−41% Bearish

Price vs 50-day avg

−27% Bearish

RSI (14)

22 Neutral

MACD trend

Negative Bearish

52-week position

15% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bullish · 2 of 6

Trend (MA cross) No cross

50d $22 › 200d $27 — 200d above 50d

Institutional flow Accumulating

+16% holders QoQ · +129 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Rising

8.03% of float · ▲ +5.3% MoM · 5.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

488 holders — near 3-yr high, broad support

Price context

position in its 52-week range

Range low $10 Now $16 · 15% Range high $51

vs 200-day avg -41% vs 50-day avg -27%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
Adjusted EBITDA profit non-GAAP	13.9M	second quarter of fiscal year 2027	—

GAAP → non-GAAP reconciliation GAAP Net loss -9.35M -6.43M Interest income +1.44M Interest expense +733K Income tax provision +10.79M Depreciation and amortization +0K Change in fair value of warrant liabilities +17.06M Stock-based compensation +0K Restructuring costs -411K Certain litigation expenses +0K Employer payroll taxes related to earnout share vesting +105K Other (income) expense, net = Adjusted EBITDA 13.93M
Adjusted free cash flow non-GAAP	28.83M	Six Months Ended July 31, 2026	—
Backlog non-GAAP	814.9M	second quarter of fiscal year 2027	—
GAAP → non-GAAP reconciliation GAAP Remaining performance obligations 753.12M +61.75M Cancelable amount of contract value = Backlog 814.86M
Free cash flow non-GAAP	21.3M	Six Months Ended July 31, 2026	—
Non-GAAP gross margin non-GAAP	59%	second quarter of fiscal year 2027	—
Percent of recurring annual contract value (ACV)	98%	second quarter of fiscal year 2027	—
Remaining Performance Obligations (RPOs)	753.1M	second quarter of fiscal year 2027	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Aerospace & Defense — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
PL Planet Labs PBC this stock	$5.86B	-18.8%	+25.9%	—	8.0%
SPCX Space Exploration Technologies Corp	$1.90T	—	—	—	1.3%
GE General Electric Co	$329.49B	-0.3%	+18.5%	37.4	1.5%
RTX RTX Corp	$261.28B	+6.6%	+17.1%	34.1	0.9%
EADSF Airbus SE/ADR	$181.25B	-4.2%	—	—	0.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

488

% held: 78.2%
Net QoQ: +29.9M sh
Top holder: Alphabet Inc.

Held Float

View

Held by Funds

Fund positions

321

View

Short & Settlement

Short Interest Rising

Shares short

29.2M

Days to cover: 5.9d
Change: +1.5M sh

View

Short Volume

Short vol %

33%

As of: Sep 15, 2026

Short Total

View

Fails to Deliver

FTD shares

189.7K

Value: $4.3M
As of: Aug 20, 2026

View

Off-Exchange

Off-exchange %

40.0%

Week of: Aug 10, 2026

Off-exch Lit

View

Smart Money

Congressional Trades Sell

Member

George Whitesides

Amount: $50.0K–$100.0K
Traded: Mar 27, 2025

View

Financials

Revenue (FY)

$307.7M

Net income (FY): $-246.9M
EPS diluted: $-0.80

View

Filings

SEC Filings

Latest

8-K

Filed: Sep 3, 2026
This year: 17

View

Proposed Sales

Value

$2.5M

Shares: 110.0K
Filed: Jul 23, 2026

View

Exempt Offerings

Offering

$52.0M

Filed: Sep 28, 2021

View

Earnings & Events

Earnings Calls

Last call

Sep 3, 2026

View

Investor Relations

	5D	20D	120D	MTD	YTD
PL	-10.1%	-34.3%	-49.7%	-19.3%	-18.8%
SPY	-1.1%	-2.0%	+16.0%	-1.3%	+11.1%
vs SPY	-8.9%	-32.3%	-65.6%	-18.0%	-29.8%

PL · Planet Labs PBC

Price & Indicators

Up next

Metrics snapshot

Equibles Research

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance